AI MARKET SCANNING

COMPASS Pathways Plc – American

📅 Next Catalyst: Nov 03, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Healthcare 🏭 Medical Care Facilities
AVG HISTORICAL GAP -0.61%
MAX GAP RECORD -31.34%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $CMPS
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 03, 2026 Earnings Release 2026-11-03 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 05, 2026 Earnings Release 2026-08-05 (BEFORE OPEN)
-1.69%
May 13, 2026 Earnings Release 2026-05-13 (BEFORE OPEN)
+5.12%
Mar 24, 2026 Earnings Release 2026-03-24 (BEFORE OPEN)
-0.75%
Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN)
+9.58%
Jul 31, 2025 Earnings Release 2025-07-31 (BEFORE OPEN)
+2.03%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+1.37%
Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN)
+15.30%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.5%
Bullish Gaps (8)
Bearish Gaps (6)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $CMPS

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗